This topic contains a solution. Click here to go to the answer

Author Question: A star of spectral type B with a mass of 10 times the mass of the Sun lives approximately how long ... (Read 24 times)

Collmarie

  • Hero Member
  • *****
  • Posts: 569
A star of spectral type B with a mass of 10 times the mass of the Sun lives approximately how long on the main sequence?
 
  A) 10 billion years
  B) 10 million years
  C) 1,000 years
  D) 10,000 years
  E) 1 billion years

Question 2

How do many of the jovian-type extrasolar planets seem to defy portions of the solar nebula theory? How can this perhaps be reconciled?
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

meganmoser117

  • Sr. Member
  • ****
  • Posts: 303
Answer to Question 1

B

Answer to Question 2

The solar nebula theory predicts the Sun's heat would drive light gases far out, making the jovian planets form far out, and letting denser terrestrials form closer in. But most of the jovians yet discovered are quite close to their home stars, perhaps due to tidal interactions causing these planets to spiral inward after they formed farther out.




Collmarie

  • Member
  • Posts: 569
Reply 2 on: Jul 27, 2018
Great answer, keep it coming :)


kishoreddi

  • Member
  • Posts: 329
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Congestive heart failure is a serious disorder that carries a reduced life expectancy. Heart failure is usually a chronic illness, and it may worsen with infection or other physical stressors.

Did you know?

Cytomegalovirus affects nearly the same amount of newborns every year as Down syndrome.

Did you know?

Atropine, along with scopolamine and hyoscyamine, is found in the Datura stramonium plant, which gives hallucinogenic effects and is also known as locoweed.

Did you know?

Anesthesia awareness is a potentially disturbing adverse effect wherein patients who have been paralyzed with muscle relaxants may awaken. They may be aware of their surroundings but unable to communicate or move. Neurologic monitoring equipment that helps to more closely check the patient's anesthesia stages is now available to avoid the occurrence of anesthesia awareness.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library